141 related articles for article (PubMed ID: 35855560)
1. Polygenic risk score in prostate cancer.
Oh JJ; Hong SK
Curr Opin Urol; 2022 Sep; 32(5):466-471. PubMed ID: 35855560
[TBL] [Abstract][Full Text] [Related]
2. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.
Chen F; Madduri RK; Rodriguez AA; Darst BF; Chou A; Sheng X; Wang A; Shen J; Saunders EJ; Rhie SK; Bensen JT; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Stanford JL; Zheng W; Sanderson M; John EM; Park JY; Xu J; Wang Y; Berndt SI; Huff CD; Yeboah ED; Tettey Y; Lachance J; Tang W; Rentsch CT; Cho K; Mcmahon BH; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Sellers TA; Yamoah K; Murphy AB; Crawford DC; Patel AV; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas CM; Stern MC; Kote-Jarai Z; Govindasami K; Cook MB; Chokkalingam AP; Hsing AW; Goodman PJ; Hoffmann TJ; Drake BF; Hu JJ; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Idowu MO; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Diop H; Van Den Eeden SK; Blanchet P; Fowke JH; Casey G; Hennis AJ; Lubwama A; Thompson IM; Leach R; Easton DF; Preuss MH; Loos RJ; Gundell SM; Wan P; Mohler JL; Fontham ET; Smith GJ; Taylor JA; Srivastava S; Eeles RA; Carpten JD; Kibel AS; Multigner L; Parent MÉ; Menegaux F; Cancel-Tassin G; Klein EA; Andrews C; Rebbeck TR; Brureau L; Ambs S; Edwards TL; Watya S; Chanock SJ; Witte JS; Blot WJ; Michael Gaziano J; Justice AC; Conti DV; Haiman CA
Eur Urol; 2023 Jul; 84(1):13-21. PubMed ID: 36872133
[TBL] [Abstract][Full Text] [Related]
3. Polygenic Risk Scores in Prostate Cancer Risk Assessment and Screening.
Byrne L; Toland AE
Urol Clin North Am; 2021 Aug; 48(3):387-399. PubMed ID: 34210493
[TBL] [Abstract][Full Text] [Related]
4. Systematic evaluation of narrow-sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort.
Wu Y; Ruan X; Gao P; Da H; Fang Z; Xu D; Jiang H; Ding Q; Lin X; Lu D; Na R
Clin Genet; 2023 Jun; 103(6):636-643. PubMed ID: 36840471
[TBL] [Abstract][Full Text] [Related]
5. An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study.
Cheng Y; Wu L; Xin J; Ben S; Chen S; Li H; Zhao L; Wang M; Cheng G; Du M
J Transl Med; 2024 Apr; 22(1):366. PubMed ID: 38632662
[TBL] [Abstract][Full Text] [Related]
6. Polygenic risk score for genetic evaluation of prostate cancer risk in Asian populations: A narrative review.
Song SH; Byun SS
Investig Clin Urol; 2021 May; 62(3):256-266. PubMed ID: 33943048
[TBL] [Abstract][Full Text] [Related]
7. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer.
Wu C; Zhu J; King A; Tong X; Lu Q; Park JY; Wang L; Gao G; Deng HW; Yang Y; Knudsen KE; Rebbeck TR; Long J; Zheng W; Pan W; Conti DV; Haiman CA; Wu L
Cancer Commun (Lond); 2021 Dec; 41(12):1387-1397. PubMed ID: 34520132
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of polygenic risk scores for predicting breast and prostate cancer risk.
Machiela MJ; Chen CY; Chen C; Chanock SJ; Hunter DJ; Kraft P
Genet Epidemiol; 2011 Sep; 35(6):506-514. PubMed ID: 21618606
[TBL] [Abstract][Full Text] [Related]
9. Towards clinical utility of polygenic risk scores.
Lambert SA; Abraham G; Inouye M
Hum Mol Genet; 2019 Nov; 28(R2):R133-R142. PubMed ID: 31363735
[TBL] [Abstract][Full Text] [Related]
10. How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis.
Siltari A; Lönnerbro R; Pang K; Shiranov K; Asiimwe A; Evans-Axelsson S; Franks B; Kiran A; Murtola TJ; Schalken J; Steinbeisser C; Bjartell A; Auvinen A;
Clin Genitourin Cancer; 2023 Apr; 21(2):316.e1-316.e11. PubMed ID: 36243664
[TBL] [Abstract][Full Text] [Related]
11. Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes.
Ruan X; Huang D; Huang J; Tsu JH; Na R
J Transl Med; 2023 Jul; 21(1):446. PubMed ID: 37415201
[TBL] [Abstract][Full Text] [Related]
12. Application of European-specific polygenic risk scores for predicting prostate cancer risk in different ancestry populations.
Ruan X; Huang D; Huang J; Xu D; Na R
Prostate; 2023 Jan; 83(1):30-38. PubMed ID: 35996327
[TBL] [Abstract][Full Text] [Related]
13. Genetic risk of prostate cancer in Ugandan men.
Du Z; Lubmawa A; Gundell S; Wan P; Nalukenge C; Muwanga P; Lutalo M; Nansereko D; Ndaruhutse O; Katuku M; Nassanga R; ; Asiimwe F; Masaba B; Kaggwa S; Namuguzi D; Kiddu V; Mutema G; Conti DV; Luke A; Job K; Henry DM; Haiman CA; Watya S
Prostate; 2018 Apr; 78(5):370-376. PubMed ID: 29356057
[TBL] [Abstract][Full Text] [Related]
14. Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy.
Akamatsu S; Terada N; Takata R; Kinoshita H; Shimatani K; Momozawa Y; Yamamoto M; Tada H; Kawamorita N; Narita S; Kato T; Nitta M; Kandori S; Koike Y; Inazawa J; Kimura T; Kimura H; Kojima T; Terachi T; Sugimoto M; Habuchi T; Arai Y; Yamamoto S; Matsuda T; Obara W; Kamoto T; Inoue T; Nakagawa H; Ogawa O
JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35118230
[TBL] [Abstract][Full Text] [Related]
15. Prediction of clinically significant prostate cancer using polygenic risk models in Asians.
Song SH; Kim E; Woo E; Kwon E; Yoon S; Kim JK; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
Investig Clin Urol; 2022 Jan; 63(1):42-52. PubMed ID: 34983122
[TBL] [Abstract][Full Text] [Related]
16. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.
Amin Al Olama A; Benlloch S; Antoniou AC; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Muir K; Schleutker J; Henderson BE; Haiman CA; Schumacher FR; Pashayan N; Pharoah PD; Ostrander EA; Stanford JL; Batra J; Clements JA; Chambers SK; Weischer M; Nordestgaard BG; Ingles SA; Sorensen KD; Orntoft TF; Park JY; Cybulski C; Maier C; Doerk T; Dickinson JL; Cannon-Albright L; Brenner H; Rebbeck TR; Zeigler-Johnson C; Habuchi T; Thibodeau SN; Cooney KA; Chappuis PO; Hutter P; Kaneva RP; Foulkes WD; Zeegers MP; Lu YJ; Zhang HW; Stephenson R; Cox A; Southey MC; Spurdle AB; FitzGerald L; Leongamornlert D; Saunders E; Tymrakiewicz M; Guy M; Dadaev T; Little SJ; Govindasami K; Sawyer E; Wilkinson R; Herkommer K; Hopper JL; Lophatonanon A; Rinckleb AE; Kote-Jarai Z; Eeles RA; Easton DF; ; ;
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1121-9. PubMed ID: 25837820
[TBL] [Abstract][Full Text] [Related]
17. Risk Allele Frequency Analysis and Risk Prediction of Single-Nucleotide Polymorphisms for Prostate Cancer.
Yoon BW; Shin HT; Seo JH
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360276
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
Roberts MR; Asgari MM; Toland AE
Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
[TBL] [Abstract][Full Text] [Related]
19. No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
Barnett GC; Kerns SL; Dorling L; Fachal L; Aguado-Barrera ME; Martínez-Calvo L; Jandu HK; Welsh C; Tyrer J; Coles CE; Haviland JS; Parker C; Gómez-Caamaño A; Calvo-Crespo P; Sosa-Fajardo P; Burnet NG; Summersgill H; Webb A; De Ruysscher D; Seibold P; Chang-Claude J; Talbot CJ; Rattay T; Parliament M; De Ruyck K; Rosenstein BS; Pharoah PDP; Dunning AM; Vega A; West CML;
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):494-501. PubMed ID: 35840111
[TBL] [Abstract][Full Text] [Related]
20. Could Polygenic Risk Scores Be Useful in Psychiatry?: A Review.
Murray GK; Lin T; Austin J; McGrath JJ; Hickie IB; Wray NR
JAMA Psychiatry; 2021 Feb; 78(2):210-219. PubMed ID: 33052393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
